Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gut-Brain Signaling Pathways Reveal Distinct Neural Responses to Fructose and Glucose Intake
Neuroscience & Brain Research

Gut-Brain Signaling Pathways Reveal Distinct Neural Responses to Fructose and Glucose Intake

Rifan Muazin Jul 12, 2026 0

Recent neurobiological research from the Monell Chemical Senses Center has unveiled a critical distinction in how the human brain processes…

Read More
Neuroscience & Brain Research

Distinct Neural Pathways for Fructose and Glucose Reveal How Different Sugars Shape Brain Response and Appetite Regulation

Rifan Muazin Jul 4, 2026 0

In a landmark study that challenges long-standing assumptions about nutrition and metabolic science, researchers at the Monell Chemical Senses Center…

Read More
Neuroscience & Brain Research

New Research Reveals Fructose and Glucose Use Distinct Neural Pathways to Control Hunger and Food Preference

Rifan Muazin Jun 27, 2026 0

The long-standing nutritional axiom that "a calorie is a calorie" is facing a significant challenge from the field of neurobiology,…

Read More
Biotech & Genetic Research

Glioblastoma Immune Cells Hijack Fructose Metabolism to Suppress Anti-Tumor Responses, Unveiling a Novel Therapeutic Pathway.

Jia Lissa Mar 20, 2026 0

In a significant breakthrough that could reshape the therapeutic landscape for one of the most aggressive and intractable brain cancers,…

Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data PlatformEli Lilly Acquires Engage Biologics for Up to $202 Million, Bolstering Its Genetic Medicine Pipeline with Innovative Non-Viral DNA Delivery TechnologyThe Future of Cell and Gene Therapy Manufacturing is Being Revolutionized by AI and Advanced Data StrategiesTWiV 1284: Clinical update with Dr. Daniel Griffin
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ